Stemcells Inc Sample Contracts

AutoNDA by SimpleDocs
ARTICLE I
Escrow Agreement • August 28th, 2002 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
WARRANT
Stemcells Inc • June 17th, 2004 • Biological products, (no disgnostic substances) • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 29th, 2023 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of June 26, 2023, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

and
Rights Agreement • August 3rd, 1998 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Delaware
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • January 30th, 2024 • Microbot Medical Inc. • Surgical & medical instruments & apparatus

This Registration Rights Agreement (this “Agreement”) is made and entered into as of January 26, 2024, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each of the several entities signatory hereto (each such entity, a “Plaintiff” and, collectively, the “Plaintiffs”).

AND
License Agreement • November 14th, 1996 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Rhode Island
STEMCELLS, INC.
Stemcells Inc • May 25th, 2001 • Biological products, (no disgnostic substances) • Delaware
ESCROW AGREEMENT
Escrow Agreement • May 25th, 2001 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
BETWEEN
Registration Rights Agreement • December 5th, 2000 • Stemcells Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.56 SUBSCRIPTION AGREEMENT DATED AS OF JUNE 21, 2001 BY AND BETWEEN STEMCELLS, INC.
Subscription Agreement • June 29th, 2001 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.58 LEASE AGREEMENT DATED AS OF NOVEMBER 21, 1997 BY AND BETWEEN
Lease Agreement • March 31st, 1998 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Maryland
WARRANT
Stemcells Inc • December 7th, 2001 • Biological products, (no disgnostic substances) • New York
SECTION 1.
Common Stock Purchase Agreement • August 28th, 2002 • Stemcells Inc • Biological products, (no disgnostic substances) • California
UNDERWRITER COMMON STOCK PURCHASE WARRANT MICROBOT MEDICAL INC.
Microbot Medical Inc. • February 8th, 2019 • Biological products, (no disgnostic substances) • New York

THIS UNDERWRITER COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six-month anniversary of the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Common Stock ($0.01 Par Value)
Agency Agreement • October 26th, 2004 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
AutoNDA by SimpleDocs
CYTOTHERAPEUTICS, INC. Two Richmond Square Providence, RI 02906 401-272-3310 September 25, 1997
Cytotherapeutics Inc/De • March 31st, 1998 • Biological products, (no disgnostic substances) • Rhode Island
PRE-FUNDED COMMON STOCK PURCHASE WARRANT Microbot Medical Inc.
Microbot Medical Inc. • February 8th, 2019 • Biological products, (no disgnostic substances) • New York

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 24th, 2023 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of May 23, 2023, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

AMONG
Securities Purchase Agreement • December 5th, 2000 • Stemcells Inc • Biological products, (no disgnostic substances) • California
EXHIBIT 10.81
Consulting Services Agreement • March 31st, 1999 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.49 SUBSCRIPTION AGREEMENT DATED AS OF JULY 31, 2000 BY AND BETWEEN STEMCELLS, INC.
Subscription Agreement • September 8th, 2000 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 31st, 2019 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 30, 2019, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

6% CONVERTIBLE DEBENTURE DUE NOVEMBER 28, 2019
Microbot Medical Inc. • November 29th, 2016 • Biological products, (no disgnostic substances) • New York

THIS 6% CONVERTIBLE DEBENTURE is one or more of a series of duly authorized and validly issued 6% Convertible Debentures of Microbot Medical Inc. (formerly known as Stemcells, Inc.), a Delaware corporation (the “Company”), having its principal place of business at 5 Hamada Street, Yokneam 2069204 Israel, designated as its 6% Convertible Debenture due November 28, 2019 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).

RECITALS
Securities Purchase Agreement • June 17th, 2004 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
RECITALS
Employment Agreement • December 5th, 2000 • Stemcells Inc • Biological products, (no disgnostic substances) • Rhode Island
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 25th, 2022 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of October 21, 2022, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

WARRANT STEMCELLS, INC.
Stemcells Inc • July 15th, 2014 • Biological products, (no disgnostic substances)

THIS WARRANT (the “Warrant”) certifies that, for value received, or its permitted assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the 6 month anniversary of the Issue Date (the “Initial Exercise Date”) and prior to the close of business on the 13 month anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from StemCells, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!